All In Biotech

Drug Trial Radar · NCT06405087

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Subcutaneous in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Oct 27, 2025

Primary completion

Aug 12, 2030

Study completion Aug 12, 2030

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
May 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main aim of this study is to learn about medical problems (adverse events) if vedolizumab subcutaneously (SC) is given to a child or teenager with UC or CD for a long time. Other aims are to understand if the long time use of vedolizumab SC has an impact on the time period until hospital visits because of bowel swelling (inflammation) are needed and has an impact on the quality of life of children and teenagers who received vedolizumab SC. In this study, participants who responded well to the treatment with vedolizumab SC in the parent study (VedolizumabSC-3003 \[NCT06100289\]) will continue to be treated with vedolizumab SC. Participants who did not respond well to the treatment with vedolizumab SC in the parent study or who received corticosteroids in the last 4 weeks of the parent study will not receive vedolizumab SC in this study but will be followed for up to 2 years after the last treatment with vedolizumab SC in the parent study. During the study, participants will visit their study clinic several times.

Conditions

  • Ulcerative Colitis
  • Crohn's Disease

Interventions

  • Vedolizumab SCDrug

    Vedolizumab subcutaneous injection.

  • No InterventionOther

    As this is an observational cohort, no intervention will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment Cohort: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: First dose of the study drug until 18 weeks of follow-up after last dose (up to Week 138)
  2. Treatment Cohort: Number of Participants With Adverse Events of Special Interests (AESIs)Time frame: First dose of the study drug until 18 weeks of follow-up after last dose (up to Week 138)
  3. Observational Cohort: Number of Participants With Prespecified Safety EventsTime frame: Up to Week 86

Locations

45 sites in 14 countries. Site status is shown where the registry gives one.

  • Phoenix Childrens Hospital

    Phoenix, Arizona · Not yet recruiting

  • Loma Linda University

    Loma Linda, California · Not yet recruiting

  • Children's Hospital of Orange County

    Orange, California · Not yet recruiting

  • Advocate Children's Hospital Park Ridge

    Park Ridge, Illinois · Not yet recruiting

  • Childrens Hospital of Michigan

    Detroit, Michigan · Not yet recruiting

  • Atlantic Health - Morristown Medical Center

    Morristown, New Jersey · Not yet recruiting

  • New York Presbyterian Hospital

    New York, New York · Not yet recruiting

  • University Children's Clinic

    Cleveland, Ohio · Not yet recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Not yet recruiting

  • The University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma · Recruiting

  • Penn State Health Milton South Hershey Medical Center

    Hershey, Pennsylvania · Not yet recruiting

  • Medical University of South Carolina

    Charleston, South Carolina · Not yet recruiting

  • Multicare Health System Institute for Research and Innovation

    Tacoma, Washington · Not yet recruiting

  • Centre Hospitalier Chretien MontLegia

    Liège, Belgium · Not yet recruiting

  • Cliniques Universitaires Saint-Luc

    Brussels, Brussels Capital, Belgium · Not yet recruiting

  • UMHAT Sv. Georgi, EAD

    Plovdiv, Bulgaria · Recruiting

  • Childrens Health Ireland at Crumlin - PIN

    Crumlin, Dublin, Ireland · Not yet recruiting

  • Azienda Ospedaliera Universitaria Gaetano Martino, Messina

    Messina, Italy · Not yet recruiting

  • ASST Fatebenefratelli Sacco - Ospedale dei Bambini Vittore Buzzi - INCIPIT - PIN

    Milan, Italy · Not yet recruiting

  • Unita Operativa Complessa Di Pediatria Medica

    Pescara, Italy · Not yet recruiting

  • Bambin Gesu Hospital - Ospedale Pediatrico Bambin Gesu

    Roma, Italy · Not yet recruiting

  • Kurume University Hospital

    Kurume-shi, Fukuoka, Japan · Not yet recruiting

  • Juntendo University Hospital

    Bunkyo-ku, Tokyo, Japan · Recruiting

  • National Center for Child Health and Development

    Setagaya-ku, Tokyo, Japan · Not yet recruiting

  • Radboud Universitair Medisch Centrum

    Nijmegen, Netherlands · Not yet recruiting

  • Korczowski Bartosz, Gabinet Lekarski

    Rzeszów, Poland · Recruiting

  • WIP Warsaw IBD Point Profesor Kierkus

    Warsaw, Poland · Recruiting

  • Instytut Pomnik - Centrum Zdrowia Dziecka

    Warsaw, Poland · Recruiting

  • Grigore Alexandrescu Emergency Clinical Hospital for Children

    Bucharest, Romania · Recruiting

  • Victor Gomoiu Clinical Hospital for Children

    Bucharest, Bucharest, Romania · Recruiting

  • University Children's Clinic

    Belgrade, Serbia · Not yet recruiting

  • Institute for Children and Youth Health Care of Vojvodina

    Novi Sad, Serbia · Not yet recruiting

  • Kyungpook National University Chilgok hospital

    Daegu, South Korea · Recruiting

  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea · Recruiting

  • Seoul National University Hospital

    Seoul, South Korea · Recruiting

  • Samsung Medical Center

    Seoul, South Korea · Not yet recruiting

  • Hospital Arquitecto Marcide de Ferrol

    Ferrol, Spain · Not yet recruiting

  • Hospital Universitario 12 de Octubre

    Madrid, Spain · Not yet recruiting

  • Hospital Universitario Virgen Macarena

    Seville, Spain · Not yet recruiting

  • Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur)

    Valencia, Spain · Not yet recruiting

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.